The story of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of knock-off medications, significantly impacting its market share . While some businesses may seek to capitalize on related treatments , the existing l